Abstract. Electrospinning is considered a relative simple and versatile technique to form high porosity porous scaffolds with micron to nanoscale fibers for biomedical applications. Here, electrospinning of unsaturated aliphatic polyglobalide (PGl) into well-defined fibers with an average diameter of 9 µm is demonstrated. Addition of a dithiol crosslinker and a photoinitiator to the polymer solution enabled the UV-triggered intra-crosslinking of the fibers during the spinning process. The in-situ crosslinking of the fibers resulted in amorphous material able to swell up to 14% in tetrahydrofyrane (THF) without losing the fiber morphology. Seeding Mesenchymal Stem Cells (MSCs) onto both crosslinked and non-crosslinked PGl fibers proved their compatibility with MSCs and suitability as scaffolds for cell growth and proliferation of MSCs. Moreover, the ability to directly load crosslinked PGl with hydrophobic molecules by soaking the fiber mesh in solution is shown with Rhodamine B and Indomethacin, a hydrophobic anti-inflammatory drug. This marks an advantage over conventional aliphatic polyesters and opens opportunities for the design of drug loaded polyester scaffolds for biomedical applications or tissue engineering.
relative simple and versatile technique and has received a great interest in the area of tissue engineering due to the ability to form high porosity porous scaffolds with micron to nanoscale fibers similar to the natural extracellular matrix (ECM). 15, 17 These fibrous degradable scaffolds provide mechanical support to host cells and create conditions for their growth and proliferation, degrading as cells produce their own ECM. 13, 17 Numerous natural and synthetic homo-and copolymers have been electrospun, including PCl and PLGA, 9, 18 to engineer scaffolds for several different tissues, such as vasculature, 19 neural, 10 tendon/ligament, 20 meniscus, 21 and bone. 22 Currently there is a demand for next generation biopolymers for electrospinning that offer additional functionality for immobilizing bioactive cues or cross-linking to enable post-spinning manipulation such as drug loading. While fiber functionalization via click-chemistry has been explored and reviewed, 23, 24 only a few examples of in-situ crosslinked electrospun fibers have been disclosed to date. In one example, Ellison reported a process in which a mixture of thioland ene-functional monomers was spun and simultaneously UV-crosslinked. 25 Hoogenboom and Sanyal produced crosslinked oxazoline fibres by a UV-triggered thiol-ene reaction, 26 while
Theato used the same technique to crosslink polybutadiene fibres. 27 To the best of our knowledge there is no example of cross-linked electrospun polyester fibers matching the versatility of PCL or PLGA. One barrier, is the quite challenging chemistry to introduce functional groups along
Here we report, for the first time, the electrospinning of poly(globalide) to produce bioresorbable microfibers (PGl-F). We further take advantage of the main chain unsaturation by electrospinning PGl with in-situ UV-initiated thiol-ene crosslinking to produce fiber meshes capable of swelling in organic solvents without losing their fibrillar structure. We demonstrate the potential of these materials as bioresobable scaffolds as well as the ability to load them with hydrophobic compounds by simple solvent soaking.
Experimental Section
Materials. Globalide was purchased from Symrise. Novozyme 435 (Candida Antarctica Lipase B immobilized on cross-linked polyacrylate beads) was purchased from Novozymes A/S.
Ethylene glycol bis(3-mercapto propionate) was purchased from Wako. Pentanedithiol, dipheyl (2,4,6-timethylbenzoyl) phenome oxide, 2-hydroxy-2-methylpropiophenone), 2,2 dimethoxy -2 -phenyl acetophenone, dichloromethane (DCM), dry toluene and PCl (M W 70 -90 kDa) were purchased from Sigma-Aldrich. Dulbecco's modified eagle medium containing high glucose (DMEM+ GlutaMAX), Fetal bovine serum (FBS), penicillin/streptomycin and insulin, transferrin, selenium premix (ITS) were purchased from Biosciences. Amphotericin B, sodium pyruvate, bovine serum albumin (BSA), dexamethasone, L-ascorbic acid 2-phosphate, linoleic acid, L-proline, and phosphate-buffered saline (PBS) were purchased from Sigma-Aldrich.
Transforming growth factor β3 (TGFβ3) was purchased from Prospec Biosciences.
General Methods
Gel Permeation Chromatography (GPC) measurements were performed using an Agilent 1200 series instrument equipped with GPC control software. All measurements were carried out using Modulus of the samples were measured. The analysis was performed, in triplicate, using a Zwick/Roell model Z2 with loading of a cell of 50N at 5 mm/min, using samples cut in dog-bone shape. X-Ray Diffraction (XRD) was carried out on a Bruker AXS D8 Advance with a 3kW tube with a copper anode using the K-alpha line. The sample was mounted on a six-axis goniometer and a locked coupled scan was used. The samples were then scanned through an angle theta and the detector was maintained at twice that angle theta. The melting point (T m ) and the melting enthalpy (ΔH m ) of the samples were measured on TA instruments Q200 DSC at heating rate of 5 °C per minute under a nitrogen atmosphere form -60 °C to 120 °C using aluminum pans.
Synthesis of polyglobalide (PGl) via enzymatic ring opening polymerization
A typical procedure for the polymerization of PGl: Globalide (2.16 g; 9.5 mmol), Novozym 435 (80 mg) and toluene (1.8 g) were placed in a Schlenk flask, which was purged with nitrogen.
Then the mixture was stirred and heated at 60 °C for 4 hours in an oil bath. To separate and inhibit the enzymes, DCM was added and Novozym 435 was then removed by filtration. Cold methanol was used to precipitate the polymer. This was then vacuum-dried at room temperature for 24 hours. Typical yields were around 60% and M n 25,000 g/mol (SEC trace and 1 H-NMR see Figure S1 and S2, ESI).
Electrospinning of PGl and PGl-X
The electrospinning of PGl and PGl-X was performed using a Spraybase electrospinning machine with a stationary collector. PGl was dissolved in DCM or THF in concentrations ranging from 10 -65% wt., a voltage range of 9-16 kV, flow rate 50-200 µL/min, and distance of the tip 10-20 cm.
The optimized electrospinning parameters for PGl were used as a reference to electrospun PGl-X. For this step PGl was dissolved in DCM at concentrations ranging from 50 -60%wt., a voltage range 8-15 kV, flow rate 50-300 µl/min, and distance of the tip 15-20 cm were used.
Two different reagents were applied as cross-linkers, ethylene glycol bis(mercapto propionate) (X-1) and 1,5-pentanedithiol (Xl-2), both were added to the polymer solutions at the proportion of 20% wt./wt. As photo-initiators two different solutions were tested, the 2,2 dimethoxy-2-phenyl acetophenone (P1) and (2,4,6 -trimethylbenzoyl) phenone oxide with 2-hydroxy-2-methylpropiophenone (P2) in a 1:1 wt/wt. The PGl samples were collected on aluminum foil and PGl-X samples were collected in methanol. All the samples were then vacuum-dried for 48 hours and stored in a desiccator until further use.
X-Ray Diffraction (XRD)
XRD was carried out on a Bruker AXS D8 Advance with a 3kW tube with a copper anode using the K-alpha line. The sample was mounted on a six-axis goniometer and a locked coupled scan was used. The samples were then scanned through an angle theta and the detector was maintained at twice that angle theta.
Degree of Swelling
The dried samples of PGl-X were cut with dimension of 1x1 cm and weighted and immersed in 20 mL of DCM. The wet samples were blot dried with a filter paper and weighed again. The degree of swelling of the samples was defined using the following equation
where M2 is the mass of swelled sample and M1 is the mass of dried samples.
Degradation of Electrospun PGl and PGl-X
To evaluate the degradation of the fibers, samples with dimensions of 1x1 cm were weighed and sterilized using UV-light for two minutes on each side. The samples were incubated in a PBS solution (0.01M, pH 7.4) for 90 days at 37 °C; three samples were used for each experimental point. After the hydrolytic degradation, the samples were rinsed with 50 mL of distilled water and dried under vacuum over 48 h. Degradation level was measured by the mass difference of the samples and converted to percentage of the initial weight.
Dye encapsulation
A sample of PGl-X with dimensions of 1x1 cm was immersed in a THF Rhodamine-B 0.1 wt.% solution for 10 min and dried under vacuum overnight. The dried sample was washed five times with 10 mL of water:ethanol 1:1 solution until an optically clear washing solution was obtained.
Indomethacin encapsulation
Drug loading capacity of the PGl-X was studied using Indomethacin ( 
Drug Release studies
The drug release performance of PGl-Xl and PGl samples were analysed by HPLC as described 
Cell viability assays
Bone marrow derived porcine stem cells (MSCs) were isolated as previously described 2 and expanded in growth media consisting of high-glucose Dulbecco's modified Eagle's medium (DMEM) GlutaMAX supplemented with 10 % fetal bovine serum (FBS), penicillin (100 U/mL)-streptomycin (100 μg/mL) and 0.25 μg/mL amphotericin B (all Gibco, Biosciences) at 20% pO2.
Electrospun scaffolds (Ø 8 mm) were punched out from the electrospun mesh and sterilized by ethylene oxide (EtO). To prepare for cell seeding, scaffolds were hydrated by progressive washes in ethanol and several washes with ultra-pure water. Scaffolds were incubated in expansion media overnight before cell seeding. At the end of passage 2, cells were trypsinized and seeded onto one side of the electrospun scaffolds at a density of 100,000 cells per scaffold. Cell-seeded scaffolds were maintained expansion medium at 20 % pO2 for 7 days, with medium changed twice. MSC-seeded scaffolds were cultured on custom-made wells suspended above the underlying tissue culture surface.
Cell Viability and Metabolic Activity Assays
Live/dead imaging was performed to qualitatively evaluate cell viability. Cell-seeded scaffolds were stained with 4 mM calcein-AM (green: 'live') and 2 mM ethidium homodimer-1 (red:
'dead') in phenol-free DMEM for 1 h at 37 °C protected from light (Live/dead viability/cytotoxicity assay, Invitrogen). Prior staining and before imaging samples were washed with PBS. Samples were examined under a scanning confocal microscope (Olympus FV1000) at an excitation and emission wavelengths of 515 and 615 nm. Cell metabolic activity was quantified via reduction of Alamar Blue following manufacturer's instructions. The reduction of alamar blue was measured after 1 day in culture. Cells plated on tissue culture plates (TCP) were used as control (n = 5). The absorbance was read at 570 nm using 600 nm as a reference wavelength.
To assess cell proliferation, cell-seeded scaffolds were collected at day 1, 3, 7 and 14, blot dried and stored at -80°C. Scaffolds were digested overnight at 60°C using 3.88 U/ml papain (n = 4).
DNA content was quantified via Picogreen assay (Quant-iT PicoGreen dsDNA Assay Kit, Invitrogen) according to manufacturer's protocol. The fluorescence emission intensity was measured at 528 nm on a plate reader (BioTek).
Statistics
Statistical difference was established at p<0.05 by ANOVA followed by Tukey's multiple comparisons test (GraphPad Prism 5, GraphPad Software). All data are reported as means ± standard deviation.
Results and Discussion
Electrospinning operating parameters such as flow rate, intensity of the electric potential and distance between the electrode and the collector can influence the obtained results. Moreover, solution properties such as viscosity, conductivity, dielectric constant, solvent boiling point and surface tension, are important parameters that affect the experimental outcome. 43, 44 These parameters must be optimized for any new polymeric material. In this work, the enzymatic polymerization of globalide (Gl) was applied resulting in an M n of 25,000 g/moL (Đ = 2.1). It should be noted that the preferred molecular weight of, for example, PCl in electrospinning is much higher (≥ 80,000 g/mol) to meet the required solution viscosity. 45, 46 The intrinsically higher solution viscosity of PGl compared to PCl for a comparable M n allowed us to formulate solutions with a sufficient viscosity at a concentration of > 30 wt%. Below this concentration, the electrospinning process was unsuccessful irrespective of the other processing conditions. As a first set-up, to optimize the parameters to electrospin PGl, the polymer was dissolved in dichloromethane (DCM) and extruded at various flow rates. It was observed that the polymer concentration influenced directly the fiber morphology and diameter ( Figure S3, ESI) .
Comparing the images, at 40 wt% PGl concentrations ( Figure 3A , B and C) beads occurred and the heterogeneity in fiber diameters tended to increase. This could be correlated to the viscoelastic and electrostatic forces to the surface tension, which results in the minimization of the surface area that tends to convert the liquid jet into spherical drops. 43 More homogeneous fibers were produced at 50 wt% polymer concentrations. A slower polymer feed rate allowed an increased time for solvent evaporation producing more well-defined microfibers ( Figure 3E We next investigated the possibility of in-situ cross-linking of the fibers. Following previous work within the group on the functionalization of PGl with multi-functional thiols, 42 we decided to test the incorporation of ethylene glycol bis(mercaptopropionate) (Xl-1) with a commonly used photoinitiator, 2,2 dimethoxy-2-phenyl acetophenone (PI-1). These were added to the polymer solution prior to electrospinning otherwise employing the previously determined optimized conditions. The solution jet and the collector was irradiated by UV light (365 nm) and the fibers collected on aluminium foil. It was observed that the fibers were inhomogeneous and were fused together ( Figure 4A ). In addition, the polymer solution was not stable and started to crosslink inside the syringe prior to electrospinning. Replacing PI-1 by a 1:1 wt/wt mixture of photoinitiators diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide and 2-hydroxy-2-methylpropiophenone (PI-2) resulted in a more stable polymer solution, however fused fibers were still observed on the collector plate ( Figure 3B ). Moreover, polymer fibers were still soluble in THF suggesting incompletely crosslinking. Therefore, Xl-1 was replaced by 1,5-pentanedithiol (Xl-2). The samples produced with the combination of Xl-2 and PI-2 presented a better fiber morphology with less conglutinated networks ( Figure 4C ), however, again issues were observed with fused fibers. To overcome this, methanol, a non-solvent for PGl was used to collect the fibers directly after they passed through the UV light. This technique was first described by Theato to prevent fibers fusing on the collector for crosslinked electrospun polybutadiene fibres. 27 Under these conditions a homogeneous fiber (diameters of 9.2 ± 1.6 µm, n=30) morphology was obtained similar to the non-cross-linked fibers ( Figure 4D ). collected on aluminum foil using Xl-1 and P-2, (C) collected on aluminum foil using Xl-2 and P-2 and (D) collected in methanol using Xl-2 and P-2.
First evidence of a successful cross-linking reaction was obtained from the fact that the fibers were not soluble in THF anymore. Spectroscopically, cross-linking was confirmed from the characteristic Raman double bond bands ( Figure 5 ) around 1660 cm -1 , which were significantly reduced for the cross-linked fibers (denoted as PGl-X) compared to the non-crosslinked fibers (denoted at PGl-F). Moreover, PGl-X samples display a signal at 1000 cm -1 characteristic of C-S bonds, which is not present in the spectrum of the PGl-F ( Figure 5 ). As a consequence of the crosslinking the degree of crystallinity of electrospun fibers was significantly reduced as evident from differential scanning calorimetry (DSC) and Wide Angle X-Ray Scattering (WAXS). While DSC melting peaks in the bulk PGl as well as in the PGl-F are located around 40°C, only a small residual melting transition is present in PGl-X (Figure S4,   ESI) . Similarly, WAXS spectra of bulk PGl and PGl-F display reflection peaks at 2θ values at 21 and 23, in agreement with the semicrystalline polymer structure, while no such peaks can be identified in PGl-X (Figure S5 , ESI). In agreement with previous studies on cross-linked PGl bars, cross-linking significantly reduces the crystallinity by disturbance of the crystalline domains, so that nearly fully amorphous fibers were obtained. 32 On the other hand, preliminary measurements confirm that the crosslinking resulted in an increase in the mechanical properties.
The tensile strength and Young's modulus increased 194% and 40% respectively, however, more detailed studies are required to fully monitor mechanical properties of the materials ( Figures S6-S8 , ESI).
One important criterion to determine the feasibility of a tissue engineering material is the hydrolytic degradation rate. Original work showed that bars of poly(macrolactone)s were neither enzymatically or hydrolytically degradable due to their hydrophobic character as well as high crystallinity. However, when electrospun we observed hydrolytic degradability of both PGl-F and PGl-X microfibers, which were attributed to the higher surface area to volume ratio of the microfibers over previously tested materials. For PGl-F a small mass loss of 9.6% (±1.6%) of a 1
x 1 cm mesh sample in PBS buffer solution was found within the first 30 days. Over the next 30 days a similar mass loss rate was found after which the degradation slowed to a mass loss of 27.6 % (±4.6%) after 90 days ( Figure S9 , ESI). PGl-X degraded slightly faster than PGl-F probably due to the amorphous character of the sample reducing 14.7% (±3.8%) of its initial mass over 30 days. The following mass loss was constant at 10% every 30 days after this, to a total mass loss of 34.3% (±1.5%) after 90 days.
Ultimately, the feasibility of using PGl for biomedical applications lies in its biocompatibility and nontoxicity. Adult mesenchymal stem cells (MSCs) have been used in preclinical models for tissue engineering of bone, cartilage, muscle, and other mesenchymal tissues with significant promise. 47 MSCs were seeded on PGl-F and PGl-X fiber meshes to assess their viability, metabolic activity and proliferation, to validate their use for tissue engineering applications.
MSCs were seeded at a density of 1 x 10 5 cells/scaffold onto one side of the PGl-F and PGl-X fiber meshes. Live/dead staining and confocal imaging was performed to qualitatively evaluate cell viability ( Figure 6A and B). MSCs remained viable on PGl-F and PGl-X electrospun fiber scaffolds after 24 h in culture. We observed minimal cell dead in both substrates. Cell metabolic activity was measured using alamarBlue reduction assay. No significant difference between PGl-F and PG-X in terms of cell viability according to their cell metabolic activity was detected ( Figure 6C ). We included a positive (cells on tissue culture plastic (TCP)) and a negative control (wells with no cells, labelled 'blank'). Long term viability and proliferation was quantified by measuring the DNA content on both PGl-F and PGl-X, using pico green assay for DNA quantification. In both scaffolds, DNA content was higher after 14 days of culture compared to day 1 ( Figure 6D ). All together these results confirm that PGl-F and PGl-X support cell viability and proliferation. To further demonstrate the drug loading capacity and efficiency of PGl-X fibers, loading of the hydrophobic anti-inflammatory drug IND was studied. In one approach, loading was achieved in a conventional process by adding IND to the spinning solution. A drawback of this approach is that the maximum loading capacity of the drug in the fibers is limited by its solubility in the spinning solution, in this case it was 10% (wt/wt) of IND relative to the total mass of PGl used.
Increasing the loading capacity is not easily possible as increasing the amount of solvent would compromise the spinning outcome. In the second approach, PGl-X fibres were soaked in a (Figure 9 ). An initial burst release regime comprising release of physisorbed drug and diffusion of drug near the surface is seen for the first 120-180 min. for all samples. 48 The burst release from PGl-X-10 and PGl-X-20 was around 65 µg/mg PGl and 140 µg/mg PGl, respectively, which were higher than for the PGl-F sample (10 µg/mg PGl) due to greater amount of physisorbed IND on the fibre surfaces. By subtracting the burst release from the total amount of IND loaded into the samples, the total amounts of IND incorporated in the bulk of the fibers can be calculated which will only be released upon fibre erosion (not further studied here), 49, 50 i.e. 90 µg/mg PGl for PGl-F, 145 µg/mg a higher drug loading is achievable by the swelling approach using crosslinked fibres but also that the total amount of drug can be controlled by the drug concentration in the swelling solution. 
Conclusions
We have demonstrated that it is possible to electrospin unsaturated PGl and by in-situ UVtriggered thiol-ene reaction produce crosslinked fibers. Initial biocompatibility and degradation tests confirm the viability of these materials for biomedical applications such as tissue engineering and drug delivery systems as an alternative to commercial aliphatic polyesters. The benefit of crosslinking was highlighted by the possibility of solvent swelling under retention of the fiber morphology. This opens possibilities to load fibers with active ingredients post spinning thereby omitting the need to optimize spinning protocols for each drug/polymer formulation.
Moreover, higher loading capacity as well as the opportunity to vary loading amounts by their concentration in the swelling medium mark an advantage over conventional polyester fibers.
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